Competition

  • April 11, 2025

    FTC Starts Process That May Nix Chevron, Exxon Deal Limits

    The Federal Trade Commission took the first steps Friday toward potentially lifting bans on the CEOs of Hess and Pioneer Natural Resources serving on the boards of Chevron and Exxon, respectively, under agreements assailed by the FTC's Republican leadership who want to permit the Chevron-Hess and Exxon-Pioneer mergers without those restrictions.

  • April 11, 2025

    AbbVie, Sandoz Settle Patent Fight Over Rinvoq Generics

    AbbVie has settled a dispute accusing Sandoz of infringing multiple patents with its proposed generic versions of AbbVie's blockbuster immunosuppressant drug Rinvoq, according to a stipulation filed Friday in Delaware federal court.

  • April 11, 2025

    Live Nation, Ticketmaster Can't Nix Consumer Antitrust Suit

    A California federal judge Friday denied a bid from Live Nation and Ticketmaster to toss an antitrust case from consumers alleging monopolization of the concert ticketing market, following a tentative ruling issued earlier this week while finding a recent antitrust win for Amazon doesn't translate to the case before him.

  • April 11, 2025

    FTC Says Chamber's Merger Notice Rule Suit Belongs In DC

    The Federal Trade Commission has asked a Texas federal judge to transfer a U.S. Chamber of Commerce regulation challenge to Washington, D.C., arguing that the only claims to Lone Star State jurisdiction are vague assertions that a local chamber's members could be affected by a new overhaul of merger filing requirements.

  • April 11, 2025

    Landlords Look To Exit DOJ's RealPage Antitrust Case

    The residential building owners accused by federal and state enforcers of violating antitrust law through their use of RealPage's software to set rental prices told a North Carolina federal court it's not against the law for companies to use the same software.

  • April 11, 2025

    5th Circ. Revives Unfair Competition Fight Over Arthritis Drug

    The Fifth Circuit has revived Zyla Life Sciences LLC's lawsuit seeking to block Texas rival Wells Pharma from selling rheumatoid arthritis drug suppositories that aren't U.S. Food and Drug Administration-approved, rejecting Wells Pharma's argument that Zyla's state claims are preempted under federal law and noting that finding otherwise would have "staggering" implications.

  • April 11, 2025

    Duke, UNC Football Players Sue NCAA Over Eligibility Waivers

    Four football players from Duke and the University of North Carolina at Chapel Hill filed two separate lawsuits in North Carolina Business Court on Friday after the NCAA denied their requests for another year of eligibility, adding to the growing list of plaintiffs protesting the organization's eligibility rules.

  • April 11, 2025

    Another Calif. Tribe Files Suit Over $700M Casino Project

    A California Native American tribe alleged in District of Columbia federal court that the federal government unlawfully placed land in a trust and approved a $700 million, 160-acre casino resort project that was proposed by another California tribe.

  • April 11, 2025

    Judge Won't Exit Broker Fee Case Over Donations To Wife

    A Missouri federal judge said a real estate firm's bid to boot him from a class action over commission fees may have been driven more by litigation strategy than ethical concerns over campaign contributions made by opposing counsel to his wife, a Kansas City councilwoman.

  • April 11, 2025

    OpenAI Says Co. Sought 'Open AI' TM After It Became Famous

    OpenAI has urged a California federal court to find that it holds senior, protectable trademark rights over a company called Open Artificial Intelligence, saying the entity "rushed" to register its name only after the ChatGPT developer began getting media attention about a decade ago.

  • April 11, 2025

    Hagens Berman Sanctioned Over Disappearing Client

    Hagens Berman Sobol Shapiro LLP is facing monetary sanctions in a proposed class action against Apple and Amazon, after a Washington federal judge said the firm misled her about a problem client who disappeared and wasted the court's time in the process.

  • April 11, 2025

    Off The Bench: A Wait On NIL Settlement, Done Deal In Soccer

    In this week's Off The Bench, the big NCAA name, image and likeness settlement still needs more work, a long-awaited settlement between U.S. Soccer and a prominent sports promotion company is completed, and a resolution of the conflict between Northwestern University and its football players is a step closer.

  • April 11, 2025

    FTC Probing Valvoline's $625M Breeze Autocare Deal

    Valvoline Inc. said Friday that the company and Greenbriar Equity Group LP have each received second requests from the Federal Trade Commission for Valvoline's proposed $625 million acquisition of Breeze Autocare from the middle market private equity firm.

  • April 11, 2025

    Trump Walks A Fine Line In Effort To Steer US Steel's Future

    Nippon's hopes of acquiring U.S. Steel were revived when President Donald Trump ordered a fresh national security review of the deal, but he faces a delicate balancing act to strike an agreement acceptable to all parties without giving a foreign power full control of the vital American steelmaker.

  • April 11, 2025

    Mich. Pot Co. Hits Vape Wholesalers With Antitrust Suit

    Redbud Roots Inc., which bills itself as Michigan's top craft cannabis cultivator, processor and supplier, is suing a group of vaporizer wholesalers, saying in the antitrust complaint that they have agreed to fix prices and keep competitors out of the market.

  • April 11, 2025

    UK Probes $3.1B SES-Intelsat Satellites Biz Merger Plan

    The Competition and Markets Authority said Friday that it is investigating SES SA's proposed $3.1 billion takeover of rival satellites operator Intelsat SA, as consolidation in the aerospace sector continues to take off to compete with Elon Musk and Jeff Bezos.

  • April 10, 2025

    Senate Confirms Meador To Fill 3rd GOP Seat AT FTC

    The U.S. Senate voted along party lines Thursday to confirm Kressin Meador Powers LLC partner Mark Meador to the Federal Trade Commission, filling the agency's third Republican seat as the spots left by the recent firing of the commission's two Democrats remain vacant. 

  • April 10, 2025

    9th Circ. Open To Sending Invisalign Antitrust Suit To Trial

    Two Ninth Circuit judges appeared open on Thursday to reversing Align's summary judgment win against a pair of class actions accusing Invisalign of monopolizing the clear braces and teeth scanners market, with one judge saying there is a triable factual dispute and another judge doubting Align's interpretation of antitrust law.

  • April 10, 2025

    Insurance Agency Accuses Former Exec Of Poaching Clients

    A Florida insurance agency has accused its former vice president of sales of poaching clients and misappropriating trade secrets when he left for a direct competitor, according to a lawsuit removed to federal court.

  • April 10, 2025

    1st Circ. Asked To Save $34M Fee Bid In JetBlue-Spirit Case

    Passengers who launched an antitrust challenge to the since-scrapped JetBlue-Spirit Airlines merger have asked the First Circuit to revive their bid to collect up to $34 million in legal fees, insisting that they paved the way for the deal to be blocked, so they should be declared the "prevailing party."

  • April 10, 2025

    Judge DQs Atty Suing FIFA Over Antitrust Allegations

    A Puerto Rican federal judge on Thursday disqualified an attorney suing FIFA and local affiliates over allegedly blocking rival soccer leagues, saying the lawyer cannot simultaneously be a plaintiff, counsel and factual witness.

  • April 10, 2025

    Grayscale Settles Bitcoin Rival's Conn. Biz Interference Suit

    Cryptocurrency firm Osprey Funds LLC and its larger digital asset management rival Grayscale Investments LLC have agreed to settle a lawsuit over the transition of a Grayscale bitcoin investment trust into an exchange-traded fund, or ETF.

  • April 10, 2025

    Pharma Cos.' Patent Practices Limit Drug Access, Report Says

    The two major pharmaceutical companies behind leading GLP-1 products are leveraging so-called patent thickets to maintain their monopolies over the diabetes and weight loss medications, a practice that can impede access to those drugs, according to a report released Thursday.

  • April 10, 2025

    Live Nation Cites Amazon's Win In Urging Nix Of Antitrust Suit

    An attorney for Live Nation Entertainment and Ticketmaster urged a California federal judge Thursday to rethink his tentative opinion to keep alive an antitrust case alleging monopolization of the concert ticketing market, saying the judge did not consider a recent Ninth Circuit decision in favor of Amazon that "maps 100%" to the case.

  • April 10, 2025

    Microsoft Pushes Back On UK's Cloud Software Findings

    Microsoft has responded to the concerns raised by Britain's competition enforcer over the cloud services market, saying that artificial intelligence is radically reshaping the space, and that any regulatory intervention could make the industry less dynamic.

Expert Analysis

  • What BT Ruling Will Mean For UK Class Actions

    Author Photo

    The Competition Appeal Tribunal’s recent dismissal of a £1.3 billion mass consumer claim against BT, the first trial decision for a U.K. collective action, reminds claimants and funders of the high bar for establishing an abuse, and provides valuable insight into how pending mass consumer cases may be resolved, say lawyers at Ashurst.

  • Overseas Investment Rule Calls For Compliance Caution

    Author Photo

    Investors should be leery of who and what they are investing in now that the federal outbound investment regime, effective Jan. 2, has extended the governement's regulatory reach to businesses and parties not previously subject to trade restrictions, says Thaddeus McBride at Bass Berry.

  • 5 Factors From Biden's Final Worker Antitrust Guidelines

    Author Photo

    The recent Federal Trade Commission and the U.S. Department of Justice's joint antitrust guidelines for business activities affecting workers cap a flurry of final announcements from the Biden administration, but it's unclear whether the agencies will maintain their support for these measures in the Trump administration, say attorneys at Simpson Thacher.

  • Calif. Cannabis Decision Deepens Commerce Clause Divide

    Author Photo

    In Peridot Tree v. Sacramento, the Eastern District of California joined a growing minority of courts that have found the dormant commerce clause inapplicable to state-regulated marijuana, and the Ninth Circuit will soon provide important guidance on this issue, say attorneys at Perkins Coie.

  • 4 Employment Law Areas Set To Change Under Trump

    Author Photo

    President Donald Trump's second term is expected to bring significant changes to the U.S. employment law landscape, including the potential for updated worker classification regulations, and challenges to diversity, equity and inclusion that are already taking shape, say attorneys at Debevoise.

  • Recent Suits Show Antitrust Agencies' Focus On HSR Review

    Author Photo

    The U.S. Department of Justice's suit this month against KKR for inaccurate and incomplete premerger filings, along with other recent cases, highlights the agency's increasing scrutiny of Hart-Scott-Rodino Act compliance for private equity firms, say attorneys at Willkie.

  • Private-Bidding Compliance Lessons From Siemens Plea Deal

    Author Photo

    Siemens Energy’s recent wire fraud conspiracy guilty plea shows that U.S. prosecutors are willing and able to police the private, domestic bidding market to protect the integrity of the competitive marketplace, and companies will need a robust compliance program to mitigate these risks, say attorneys at Foley Hoag.

  • FTC Report On AI Sector Illuminates Future Enforcement

    Author Photo

    The Federal Trade Commission's report on cloud service providers and their partnerships with developers of artificial intelligence's large language models suggests that the agency will move to rein in Big Tech with antitrust enforcement to protect startups, say attorneys at Squire Patton.

  • Mentorship Resolutions For The New Year

    Author Photo

    Attorneys tend to focus on personal achievements or career milestones when they set yearly goals, but one important area often gets overlooked in this process — mentoring relationships, which are some of the most effective tools for professional growth, say Kelly Galligan at Rutan & Tucker and Andra Greene at Phillips ADR.

  • Algorithm Price-Fixing Ruling May Lower Antitrust Claims Bar

    Author Photo

    A Washington federal court's refusal to dismiss Duffy v. Yardi Systems, an antitrust case over rent prices allegedly inflated by revenue management software, creates an apparent split in the lower courts over how to assess such claims, say attorneys at Morgan Lewis.

  • Series

    Coaching Little League Makes Me A Better Lawyer

    Author Photo

    While coaching poorly played Little League Baseball early in the morning doesn't sound like a good time, I love it — and the experience has taught me valuable lessons about imperfection, compassion and acceptance that have helped me grow as a person and as a lawyer, says Alex Barnett at DiCello Levitt.

  • 5 Litigation Funding Trends To Note In 2025

    Author Photo

    Lawyers and their clients must be prepared to navigate an evolving litigation funding market in 2025, made more complicated by a new administration and the increasing overall cost of litigation, says Jeffery Lula at GLS Capital.

  • How FTC Sent A $5.6M Warning Against Jumping The Gun

    Author Photo

    The Federal Trade Commission's recent record $5.6 million "gun jumping" action against Verdun Oil, for allegedly exerting control over EP Energy before the mandatory waiting period under U.S. antitrust law expired, warns companies that they must continue to operate independently during review, say attorneys at Ballard Spahr.

  • Predicting Where State AGs Will Direct Their Attention In 2025

    Author Photo

    In 2025, we expect state attorneys general will navigate a new presidential administration while continuing to further regulate and police financial services, artificial intelligence, junk fees and antitrust, say attorneys at Troutman Pepper.

  • A Look At FDA's Plans To Establish New OTC Drug Category

    Author Photo

    The U.S. Food and Drug Administration's recently finalized rule, creating a new over-the-counter pathway for drugs when patients satisfy certain conditions, may be useful for off-patent drugs with established safety records, though switching to OTC comes with additional costs and considerations, say attorneys at Skadden.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!